Annapolis Financial Services’s AbbVie ABBV Stock Holding History

Annapolis Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$97.9K	Buy	496 +42	+9%	+$7.84K	0.03%	119
2024 Q2	$77.9K	Hold	454	–	–	0.03%	127
2024 Q1	$82.7K	Sell	454 -191	-30%	-$32.9K	0.03%	121
2023 Q4	$100K	Sell	645 -458	-42%	-$66.8K	0.03%	149
2023 Q3	$164K	Hold	1,103	–	–	0.05%	119
2023 Q2	$149K	Buy	1,103 +16	+1%	+$2.35K	0.04%	126
2023 Q1	$173K	Sell	1,087 -2	-0.2%	-$306	0.05%	116
2022 Q4	$176K	Sell	1,089 -10	-0.9%	-$1.53K	0.06%	115
2022 Q3	$147K	Hold	1,099	–	–	0.05%	118
2022 Q2	$168K	Buy	1,099 +2	+0.2%	+$306	0.06%	114
2022 Q1	$178K	Hold	1,097	–	–	0.06%	113
2021 Q4	$149K	Buy	1,097 +307	+39%	+$36.3K	0.05%	126
2021 Q3	$85K	Buy	790 +180	+30%	+$20.6K	0.03%	143
2021 Q2	$69K	Sell	610 -173	-22%	-$19.5K	0.02%	146
2021 Q1	$85K	Hold	783	–	–	0.03%	130
2020 Q4	$84K	Buy	+783	New	+$75.2K	0.03%	124

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Annapolis Financial Services's ABBV Position: Q3 2024 in Review

Annapolis Financial Services increased its AbbVie (ABBV) stake by 9.3% in Q3 2024, buying an estimated $7.84K and bringing the position to 496 shares worth $97.9K. The position accounts for 0.03% of the portfolio, ranked #119.

Annapolis Financial Services first reported a position in ABBV in Q4 2020 and has held it in 16 quarters since. The position peaked at $178K in Q1 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Annapolis Financial Services held 496 shares of AbbVie worth $97.9K as of Q3 2024.
Annapolis Financial Services bought 42 AbbVie shares in Q3 2024, an estimated $7.84K.
AbbVie made up 0.03% of Annapolis Financial Services's portfolio in Q3 2024, its #119 holding.
Annapolis Financial Services first reported a position in AbbVie in Q4 2020 and has held it in 16 quarters since.
Annapolis Financial Services's AbbVie position peaked at $178K in Q1 2022.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.